GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/7/2026 5:25:48 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $166,458 -98.5% | Assets $62,879,694 | EPS -$0.29 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/4/2026 5:22:25 PM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $166,458 -98.5% | Assets $62,879,694 | EPS -$0.29 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/26/2026 6:03:24 AM | View | Proxy | SEC | Y 2025 | ||||||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/8/2026 5:15:51 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $9,131,317 -22.0% | Assets $70,995,020 | EPS -$0.22 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/5/2026 5:35:13 PM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $9,131,317 -22.0% | Assets $70,995,020 | EPS -$0.22 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/9/2026 5:03:34 PM | View | Proxy | SEC | Y 2025 | ||||||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/9/2026 6:12:18 AM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $44,521,431 +17.6% | Assets $76,823,992 | EPS -$0.19 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/3/2026 5:11:58 PM | View | Financials | Earnings | SEC | Y 2025 | Rev $13,678,651 +31.1% | Assets $76,823,992 | EPS -$0.09 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/7/2025 5:16:46 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $8,292,362 -8.7% | Assets $65,898,560 | EPS -$0.13 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/4/2025 5:12:22 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $8,292,362 -8.7% | Assets $65,898,560 | EPS -$0.13 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/8/2025 5:13:07 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $10,837,363 +10.0% | Assets $67,907,149 | EPS -$0.05 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/5/2025 5:06:17 PM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $10,837,363 +10.0% | Assets $67,907,149 | EPS -$0.05 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/9/2025 5:16:45 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $11,713,055 +37.8% | Assets $69,935,878 | EPS $0.08 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/6/2025 5:02:26 PM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $11,713,055 +37.8% | Assets $69,935,878 | EPS $0.08 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/10/2025 5:02:02 PM | View | Proxy | SEC | Y 2024 | ||||||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/7/2025 5:22:16 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $37,867,945 -4.3% | Assets $75,583,410 | EPS -$0.46 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/4/2025 5:10:57 PM | View | Financials | Earnings | SEC | Y 2024 | Rev $10,435,569 +11.6% | Assets $75,583,410 | EPS -$0.14 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/8/2024 5:20:19 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $9,085,826 -9.9% | Assets $76,747,513 | EPS -$0.11 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/7/2024 5:15:17 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $9,085,826 -9.9% | Assets $76,747,513 | EPS -$0.11 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/9/2024 5:19:13 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $9,848,849 -9.6% | Assets $78,519,175 | EPS -$0.08 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/6/2024 5:08:36 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $9,848,849 -9.6% | Assets $78,519,175 | EPS -$0.08 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/10/2024 4:47:09 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $8,497,701 -7.9% | Assets $81,509,518 | EPS -$0.14 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/7/2024 5:15:24 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $8,497,701 -7.9% | Assets $81,509,518 | EPS -$0.14 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/13/2024 5:04:09 PM | View | Proxy | SEC | Y 2023 | ||||||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/13/2024 6:15:43 AM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $39,552,507 -5.9% | Assets $81,776,075 | EPS -$0.44 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/5/2024 5:11:30 PM | View | Financials | Earnings | SEC | Y 2023 | Rev $9,353,066 +2.5% | Assets $81,776,075 | EPS -$0.44 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/13/2023 8:45:15 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $10,085,926 -11.6% | Assets $87,750,944 | EPS -$0.07 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/7/2023 5:22:34 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $10,085,926 -11.6% | Assets $87,750,944 | EPS -$0.07 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/11/2023 5:17:09 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $10,888,877 +5.7% | Assets $89,375,360 | EPS $0.06 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/8/2023 5:24:42 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $10,888,877 +5.7% | Assets $89,375,360 | EPS $0.06 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/12/2023 5:13:46 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $9,224,638 -17.5% | Assets $89,468,635 | EPS $0.01 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/9/2023 5:08:44 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $9,224,638 -17.5% | Assets $89,468,635 | EPS $0.01 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/15/2023 7:42:11 AM | View | Proxy | SEC | Y 2022 | ||||||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/13/2023 5:17:53 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $42,010,949 +16.7% | Assets $92,925,158 | EPS -$0.38 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/7/2023 5:22:47 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $9,123,680 +9.7% | Assets $92,925,158 | EPS -$0.17 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/14/2022 5:25:12 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $11,413,072 +41.4% | Assets $90,776,553 | EPS -$0.03 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/8/2022 5:10:15 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $11,413,072 +41.4% | Assets $90,776,553 | EPS -$0.03 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/12/2022 5:27:36 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $10,299,152 +13.7% | Assets $92,517,637 | EPS -$0.09 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/9/2022 8:53:22 PM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $10,299,152 +13.7% | Assets $92,517,637 | EPS -$0.09 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/13/2022 5:22:52 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $11,175,045 +6.1% | Assets $96,697,106 | EPS -$0.09 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/10/2022 5:14:18 PM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $11,175,045 +6.1% | Assets $96,697,106 | EPS -$0.09 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/16/2022 5:10:31 PM | View | Proxy | SEC | Y 2021 | ||||||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/11/2022 5:22:50 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $35,985,043 -3.9% | Assets $84,459,798 | EPS -$0.24 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/8/2022 5:17:32 PM | View | Financials | Earnings | SEC | Y 2021 | Rev $8,319,861 -18.9% | Assets $84,459,798 | EPS -$0.26 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/12/2021 5:23:15 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $8,072,540 -12.7% | Assets $87,570,774 | EPS -$0.07 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/9/2021 5:33:42 PM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $8,072,540 -12.7% | Assets $87,570,774 | EPS -$0.07 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/13/2021 5:13:28 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $9,055,483 -5.7% | Assets $88,851,474 | EPS $0.08 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/10/2021 5:16:34 PM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $9,055,483 -5.7% | Assets $88,851,474 | EPS $0.08 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/14/2021 5:24:48 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $10,537,159 +26.5% | Assets $93,348,025 | EPS $0.01 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/11/2021 5:16:47 PM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $10,537,159 +26.5% | Assets $93,348,025 | EPS $0.01 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/15/2021 5:03:09 PM | View | Proxy | SEC | Y 2020 | ||||||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/12/2021 5:24:20 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $37,441,134 +8.9% | Assets $96,463,305 | EPS -$0.22 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/9/2021 5:17:09 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $10,261,534 +10.3% | Assets $96,463,305 | EPS -$0.06 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/13/2020 5:21:51 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $9,250,689 +33.4% | Assets $96,009,629 | EPS -$0.03 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/10/2020 5:16:49 PM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $9,250,689 +33.4% | Assets $96,009,629 | EPS -$0.03 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/14/2020 5:15:31 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $9,598,177 +1.9% | Assets $97,523,455 | EPS -$0.06 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/11/2020 5:18:22 PM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $9,598,177 +1.9% | Assets $97,523,455 | EPS -$0.06 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 7/24/2020 5:21:27 PM | Micro | View | Financials | 10-Q/A | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $8,330,734 -4.6% | Assets $97,419,137 | EPS -$0.07 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/22/2020 5:24:09 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $8,330,734 -4.6% | Assets $97,419,137 | EPS -$0.07 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/20/2020 5:21:40 PM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $8,330,734 -4.6% | Assets $97,419,137 | EPS -$0.07 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/20/2020 5:25:34 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $34,388,295 +17.2% | Assets $104,549,283 | EPS -$0.23 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/20/2020 5:18:14 PM | View | Proxy | SEC | Y 2019 | ||||||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/18/2020 5:18:00 PM | View | Financials | Earnings | SEC | Y 2019 | Rev $9,305,553 -11.3% | Assets $104,549,283 | EPS -$0.06 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/13/2019 5:37:00 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $6,935,439 -18.3% | Assets $103,765,900 | EPS -$0.13 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/12/2019 5:17:39 PM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $6,935,439 -18.3% | Assets $103,765,900 | EPS -$0.13 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/14/2019 5:47:45 PM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $9,417,443 -7.3% | Assets $107,546,224 | EPS -$0.04 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/14/2019 5:35:48 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $9,417,443 -7.3% | Assets $107,546,224 | EPS -$0.04 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/15/2019 5:51:10 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $8,729,860 +1.7% | Assets $114,617,629 | ||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/14/2019 5:27:53 PM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $8,729,860 +1.7% | Assets $114,617,629 | Export Earnings Model | ||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/14/2019 5:22:13 PM | View | Proxy | SEC | Y 2018 | ||||||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/12/2019 6:36:56 AM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $29,344,894 -28.7% | Assets $112,693,868 | EPS -$0.45 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 2/26/2019 5:14:06 PM | View | Financials | Earnings | SEC | Y 2018 | Rev $10,487,842 -10.0% | Assets $112,693,868 | EPS -$0.14 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/14/2018 5:27:36 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $8,492,530 -24.2% | Assets $87,432,076 | EPS -$0.11 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/13/2018 5:13:13 PM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $8,492,530 -24.2% | Assets $87,432,076 | EPS -$0.11 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/14/2018 5:26:30 PM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $10,163,724 +17.3% | Assets $90,444,641 | EPS -$0.05 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/14/2018 5:26:12 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $10,163,724 +17.3% | Assets $90,444,641 | EPS -$0.05 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/9/2018 5:45:35 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $8,587,605 -10.9% | Assets $91,094,840 | EPS -$0.15 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/8/2018 5:22:15 PM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $8,587,605 -10.9% | Assets $91,094,840 | EPS -$0.15 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/15/2018 6:32:18 AM | View | Proxy | SEC | Y 2017 | ||||||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/9/2018 5:07:21 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $41,150,131 +24.6% | Assets $93,232,312 | EPS -$0.50 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/9/2018 4:56:30 PM | View | Financials | Earnings | SEC | Y 2017 | Rev $11,649,288 +28.3% | Assets $93,232,312 | EPS -$0.05 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/8/2017 5:22:21 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $11,196,961 +27.4% | Assets $90,351,057 | EPS -$0.05 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/8/2017 5:11:03 PM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $11,196,961 +27.4% | Assets $90,351,057 | EPS -$0.05 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/9/2017 5:14:15 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $8,667,127 +16.9% | Assets $87,802,792 | EPS -$0.32 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/9/2017 5:04:12 PM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $8,667,127 +16.9% | Assets $87,802,792 | EPS -$0.32 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/15/2017 6:05:27 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $9,636,755 +24.5% | Assets $91,861,605 | EPS -$0.08 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/15/2017 5:00:39 PM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $9,636,755 +24.5% | Assets $91,861,605 | EPS -$0.08 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/20/2017 5:27:42 PM | View | Proxy | SEC | Y 2016 | ||||||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/16/2017 5:07:00 PM | View | Proxy | SEC | Y 2016 | ||||||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/13/2017 5:30:00 AM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $33,025,560 -1.5% | Assets $93,404,566 | EPS -$0.06 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/10/2017 5:06:08 PM | View | Financials | Earnings | SEC | Y 2016 | Rev $9,081,440 +13.0% | Assets $93,404,566 | EPS -$0.05 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/3/2016 5:17:09 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $8,791,753 +11.5% | Assets $91,074,271 | EPS $0.01 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/3/2016 5:14:35 PM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $8,791,753 +11.5% | Assets $91,074,271 | EPS $0.01 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/5/2016 5:08:10 PM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $7,414,835 -16.8% | Assets $87,888,930 | Export Earnings Model | ||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/5/2016 5:05:00 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $7,414,835 -16.8% | Assets $87,888,930 | ||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/13/2016 4:52:53 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $7,737,532 -10.9% | Assets $89,205,734 | EPS -$0.02 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/13/2016 4:47:06 PM | View | Financials | Earnings | SEC | 1Q 2016 | Rev $7,737,532 -10.9% | Assets $89,205,734 | EPS -$0.02 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/16/2016 5:18:08 PM | View | Proxy | SEC | Y 2015 | ||||||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/14/2016 5:24:12 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $33,519,051 -9.2% | Assets $91,918,959 | EPS $0.04 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/9/2016 5:18:04 PM | View | Financials | Earnings | SEC | Y 2015 | Rev $8,037,488 -13.8% | Assets $91,918,959 | EPS $0.01 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/6/2015 5:12:28 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $7,885,048 -19.0% | Assets $92,059,237 | EPS $0.01 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/6/2015 5:08:53 PM | View | Financials | Earnings | SEC | 3Q 2015 | Rev $7,885,048 -19.0% | Assets $92,059,237 | EPS $0.01 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/7/2015 5:06:33 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $8,909,741 -8.6% | Assets $92,916,727 | EPS $0.02 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/7/2015 5:04:55 PM | View | Financials | Earnings | SEC | 2Q 2015 | Rev $8,909,741 -8.6% | Assets $92,916,727 | EPS $0.02 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/15/2015 5:03:06 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $8,686,774 +7.3% | Assets $92,189,835 | ||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/8/2015 4:57:43 PM | View | Financials | Earnings | SEC | 1Q 2015 | Rev $8,686,774 +7.3% | Assets $92,189,835 | Export Earnings Model | ||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/9/2015 5:18:52 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $36,901,871 +15.2% | Assets $95,405,114 | EPS $0.14 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/4/2015 5:26:17 PM | View | Financials | Earnings | SEC | Y 2014 | Rev $9,329,412 +14.3% | Assets $95,405,114 | EPS $0.04 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/7/2014 5:01:12 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $9,729,047 +49.0% | Assets $93,904,132 | EPS $0.04 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/7/2014 4:53:41 PM | View | Financials | Earnings | SEC | 3Q 2014 | Rev $9,729,047 +49.0% | Assets $93,904,132 | EPS $0.04 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/8/2014 5:03:36 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $9,750,168 +37.7% | Assets $93,468,664 | EPS $0.04 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/8/2014 5:02:08 PM | View | Financials | Earnings | SEC | 2Q 2014 | Rev $9,750,168 +37.7% | Assets $93,468,664 | EPS $0.04 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/16/2014 8:25:16 PM | View | Financials | Earnings | SEC | 1Q 2014 | Rev $8,093,244 -21.1% | Assets $91,106,132 | EPS $0.02 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/12/2014 5:07:16 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $8,093,244 -21.1% | Assets $91,106,132 | EPS $0.02 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/12/2014 5:31:26 PM | View | Proxy | SEC | Y 2013 | ||||||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/11/2014 5:18:17 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Rev: $32,027,462 -34.4% | Assets $87,613,738 | EPS -$0.11 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/7/2014 5:13:00 PM | View | Financials | Earnings | SEC | Y 2013 | Rev $8,159,667 -40.4% | Assets $87,613,738 | EPS -$0.08 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/6/2013 5:26:59 PM | View | Financials | Earnings | SEC | 3Q 2013 | Rev $6,528,575 -47.9% | Assets $91,911,297 | EPS -$0.04 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/6/2013 5:09:58 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $6,528,575 -47.9% | Assets $91,911,297 | EPS -$0.04 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/9/2013 5:13:20 PM | View | Financials | Earnings | SEC | 2Q 2013 | Rev $7,081,088 -42.7% | Assets $95,465,610 | EPS -$0.03 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/9/2013 5:07:06 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Rev: $7,081,088 -42.7% | Assets $95,465,610 | EPS -$0.03 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/8/2013 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Rev: $10,258,132 +0.0% | Assets $98,277,750 | EPS $0.05 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/3/2013 5:06:32 PM | View | Financials | Earnings | SEC | 1Q 2013 | Rev $10,258,132 +0.0% | Assets $98,277,750 | EPS $0.05 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/14/2013 4:31:12 PM | View | Proxy | SEC | Y 2012 | ||||||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/12/2013 5:04:32 PM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Rev: $48,851,237 -4.5% | Assets $98,593,731 | EPS $0.30 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/1/2013 5:53:29 PM | View | Financials | Earnings | SEC | Y 2012 | Rev $13,696,366 +5.1% | Assets $98,593,731 | EPS $0.09 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/2/2012 5:00:39 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Rev: $12,531,719 -4.0% | Assets $96,933,796 | EPS $0.10 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/1/2012 4:57:02 PM | View | Financials | Earnings | SEC | 3Q 2012 | Rev $12,531,719 -4.0% | Assets $96,933,796 | EPS $0.10 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/9/2012 5:17:01 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2012 ending: 6/30/2012 | Rev: $12,366,940 -14.1% | Assets $95,380,596 | EPS $0.09 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/2/2012 5:07:49 PM | View | Financials | Earnings | SEC | 2Q 2012 | Rev $12,366,940 -14.1% | Assets $95,380,596 | EPS $0.09 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/4/2012 5:18:07 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Rev: $10,256,212 -3.9% | Assets $94,568,144 | EPS $0.02 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/3/2012 5:24:59 PM | View | Financials | Earnings | SEC | 1Q 2012 | Rev $10,256,212 -3.9% | Assets $94,568,144 | EPS $0.02 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/12/2012 6:11:01 AM | View | Proxy | SEC | Y 2011 | ||||||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/7/2012 5:29:06 PM | Micro | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Rev: $51,142,776 +11.5% | Assets $95,518,316 | EPS $0.28 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/1/2012 4:40:23 PM | View | Financials | Earnings | SEC | Y 2011 | Rev $13,031,830 +1.7% | Assets $95,518,316 | EPS $0.04 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/7/2011 5:01:08 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | Rev: $13,054,278 +7.1% | Assets $96,078,666 | EPS $0.09 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/3/2011 5:19:36 PM | View | Financials | Earnings | SEC | 3Q 2011 | Rev $13,054,278 +7.1% | Assets $96,078,666 | EPS $0.09 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/8/2011 5:15:50 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2011 ending: 6/30/2011 | Rev: $14,389,741 +34.0% | Assets $94,581,055 | EPS $0.11 | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/5/2011 10:17:56 AM | View | Financials | Earnings | SEC | 2Q 2011 | Rev $14,389,741 +34.0% | Assets $94,581,055 | EPS $0.11 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/5/2011 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2011 | Rev $10,666,927 | EPS $0.03 | Export Earnings Model | ||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/11/2011 6:45:50 PM | View | Proxy | SEC | Y 2010 | ||||||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/9/2011 12:00:00 AM | View | Financials | Earnings | SEC | Y 2010 | Rev $12,814,914 | Assets $92,054,054 | EPS $0.04 | Export Earnings Model | |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/12/2010 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2010 | Rev $12,190,870 | EPS $0.05 | Export Earnings Model | ||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/16/2010 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2010 | Rev $10,739,935 | EPS $0.01 | Export Earnings Model | ||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 5/14/2010 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2010 | Export Earnings Model | ||||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/19/2010 9:11:37 PM | View | Proxy | SEC | Y 2009 | ||||||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 3/11/2010 12:00:00 AM | View | Financials | Earnings | SEC | Y 2009 | Export Earnings Model | ||||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 11/10/2009 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2009 | Export Earnings Model | ||||
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | 8/28/2009 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2009 | Export Earnings Model |